RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration.
Level 5 - mechanism / opinion, no new human data
Bench and animal research in mouse models without human data.
PubMed 25607368 · doi:10.1038/nature14142
What was done
Researchers examined structural synaptic plasticity after cooling and rewarming in mouse models of neurodegenerative disease (prion-infected and 5XFAD Alzheimer-type mice). They assessed the induction of the cold-shock protein RBM3 and tested the effects of lentiviral or hypothermia-induced RBM3 overexpression as well as RBM3 knockdown on synapse reassembly, behavioral deficits, neuronal loss, and survival.
What was found
The abstract reports no numerical values. Synaptic regeneration capacity after cooling declined in parallel with failed RBM3 induction in both disease models. Overexpressing RBM3 in the hippocampus restored synapse reassembly after cooling, sustained synaptic protection, prevented behavioral deficits and neuronal loss, and significantly prolonged survival. Conversely, RBM3 knockdown exacerbated synapse loss, accelerated disease progression, and abolished the protective effects of cooling.
Why it matters
This study identifies RBM3-mediated synaptic regeneration as a functional mechanism underlying cooling-induced neuroprotection, highlighting cold-shock pathways as potential therapeutic targets for neurodegenerative disorders.
Limits
No quantitative data, effect sizes, or sample sizes are reported in the abstract. The research was conducted exclusively in rodent models, so therapeutic applicability, safety, and translatability to human neurodegenerative diseases remain unproven.
Cited by
- supports A Nature study showed that cold stress protected against Alzheimer's disease in transgenic animal models when applied in early life, but had no protective effect when applied in midlife.